siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

Nucleic Acids Res. (2008) 36, e2

The authors for this paper wish to apologize for an error in figure 1 of their paper. The correct version appears below.

Figure 1.

A: Design of ret/PTC1 small interfering RNAs (siRNAs). Location of ret/PTC1 sense sequence of siRNA nos. 1, 2, 3, 4 and 5 examined in this study are shown under the junction sequence of ret/PTC1. The ret part of the oncogene is presented on the right part (▪). B: The control sequence is the sequence #5 with four mismatches. Mismatch site is shown in boxes. C: Structure of the shRNA1 and negative control shRNA.